Dicerna Pharmaceuticals Inc (DRNA) Stock Analyst Earnings Estimates
NASDAQ:DRNA - Nasdaq - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.2M 520.00% | 23.9M 285.48% | 164.3M 587.45% | 182.472M 11.06% | 205.938M 12.86% | 175.911M -14.58% | 170.977M -2.80% | 169.506M -0.86% | |
| EBITDA YoY % growth | -60.5M -18.86% | -126.9M -109.75% | -111M 12.53% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -61.3M -18.57% | -128.2M -109.14% | -113.2M 11.70% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -988.71% | -536.40% | -68.90% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.62 49.85% | -1.76 -8.64% | -1.52 13.64% | -1.72 -13.03% | -2.04 -18.98% | -2.68 -31.18% | -1.97 26.55% | -1.48 25.08% |
| Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 -12.88% | -0.68 -74.27% | -0.71 -34.59% | -0.50 -126.33% | -0.71 -28.17% |
| Revenue Q2Q % growth | 42.092M 2.76% | 34.695M -27.11% | 33.675M -18.53% | 33.145M -47.35% | 31.722M -24.64% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -0.22 24.14% | -0.47 | 0.25 | 53.46% |
| Q2 2021 Q2Q % growth | -0.53 -23.26% | 0.42 | -0.95 | -226.24% |
| Q1 2021 Q2Q % growth | -0.39 -25.81% | -0.38 | -0.01 | -3.09% |
| Q4 2020 Q2Q % growth | -0.49 15.52% | -0.03 | -0.46 | -1,672.01% |
| Q3 2020 Q2Q % growth | -0.29 35.56% | -0.20 | -0.09 | -42.56% |
| Q2 2020 Q2Q % growth | -0.43 -22.86% | 0.10 | -0.53 | -520.31% |
| Q1 2020 Q2Q % growth | -0.31 18.42% | 0.27 | -0.58 | -214.04% |
| Q4 2019 Q2Q % growth | -0.58 | 0.57 | -1.15 | -202.11% |
| Q3 2019 Q2Q % growth | -0.45 | -0.29 | -0.16 | -54.92% |
| Q2 2019 Q2Q % growth | -0.35 | -0.32 | -0.03 | -10.91% |
| Q1 2019 Q2Q % growth | -0.38 | -0.23 | -0.15 | -65.58% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 62.954M 28.79% | 44.657M | 18.297M | 40.97% |
| Q2 2021 Q2Q % growth | 41.337M 2.19% | 93.117M | -51.78M | -55.61% |
| Q1 2021 Q2Q % growth | 47.6M 39.88% | 47.202M | 398.256K | 0.84% |
| Q4 2020 Q2Q % growth | 40.96M 478.53% | 68.597M | -27.637M | -40.29% |
| Q3 2020 Q2Q % growth | 48.88M 507.96% | 52.53M | -3.65M | -6.95% |
| Q2 2020 Q2Q % growth | 40.45M 612.15% | 63.546M | -23.096M | -36.35% |
| Q1 2020 Q2Q % growth | 34.03M 994.21% | 61.024M | -26.994M | -44.24% |
| Q4 2019 Q2Q % growth | 7.08M | 86.445M | -79.365M | -91.81% |
| Q3 2019 Q2Q % growth | 8.04M | 11.281M | -3.241M | -28.73% |
| Q2 2019 Q2Q % growth | 5.68M | 10.495M | -4.815M | -45.88% |
| Q1 2019 Q2Q % growth | 3.11M | 10.505M | -7.395M | -70.40% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |